2024-12-01 - Analysis Report
## UnitedHealth Group Inc (UNH) Stock Analysis Report

**1. Performance Comparison & Divergence:**

UnitedHealth Group Inc (UNH), a diversified healthcare company providing health insurance, managed care, and related services, has significantly outperformed the S&P 500 (VOO) over the analyzed period.  The cumulative return for UNH is 211.88%, while the S&P 500's is 130.06%. This represents a difference of 81.8 percentage points.  The provided relative divergence of 51.6% indicates that UNH's performance is in the upper half of its historical performance range relative to the S&P 500.

The provided CAGR data shows consistently high growth rates for UNH, ranging from 29% to 113% over various two-year periods.  However, it's crucial to note that the Alpha consistently being 0.0 suggests its returns may largely track the market, despite the higher overall return. The high Beta values (>1) indicate significant market sensitivity, meaning the stock is more volatile than the overall market.


**2. Recent Price Movement:**

* **Closing Price:** $610.20 (Last Market: $614.05)
* **5-Day Moving Average:** $604.41
* **20-Day Moving Average:** $596.41
* **60-Day Moving Average:** $585.18

The stock price is currently trading slightly below its last market close and above its 5, 20, and 60-day moving averages, suggesting a relatively strong short-term trend. The gap between the last market close and the current closing price suggests a minor correction.

**3. Technical Indicators & Expected Return:**

* **RSI:** 47.45 – This indicates the stock is nearing the neutral zone, neither overbought nor oversold.
* **PPO:** 0.18 – A positive PPO suggests bullish momentum.
* **Relative Divergence (20-Day):** NaN (-) -  The lack of data prevents interpretation, but the description indicates a recent short-term decline.
* **Expected Return (Long-Term):** 167.6% - This suggests significantly higher returns than the S&P 500 over a long-term (2+ years) investment horizon assuming current trends continue.  This is a substantial projection and relies heavily on the long-term assumptions remaining valid.

The provided information indicates a moderately bullish signal considering the price action, PPO, and high long-term expected return.  However, the absence of recent divergence data necessitates caution.  A significant price jump from $610.20 to $614.05 in the most recent market trading session could indicate the start of a sudden upward trend.


**4. Recent Earnings Analysis:**

The provided earnings data reveals some inconsistencies. There's a duplicate entry for 2024-11-04.  Ignoring the duplicate, the analysis is as follows:

* **Latest Quarterly Results:**  The most recent quarter (ending 2024-11-04) showed a significant EPS increase compared to the previous quarter (2024-08-09) ($6.56 vs. $4.58).  However, the quarter before that (2024-05-09) reported a negative EPS, significantly impacting the overall trend.  Revenue remained relatively stable around $100 Billion for most quarters.
* **Revenue Growth Trends:** Revenue growth is inconsistent, showing fluctuations around $90-$100 Billion.  A clear upward trend is not evident from this limited data.
* **EPS Trends and Significant Changes:** EPS shows significant volatility, with a sharp increase followed by a large negative value and then another strong increase.  This indicates substantial quarter-to-quarter variability.
* **Beats or Misses:**  No expectations are provided for comparison, therefore, it's impossible to determine if there were any beats or misses.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has remained relatively stable over the past year, fluctuating around the $98 billion mark. Profit margins are generally strong (above 20%), though there is some recent fluctuation. The significant drop in profit margin from 24.51% to 21.56% over the last two quarters is noticeable and should be investigated.
* **Capital and Profitability:** Equity shows a general upward trend. ROE is volatile, with negative values observed in Q1 2024. This points to the need for further financial analysis.

**6. News and Recent Issues:**

No specific news or recent market outlook is provided.  Lack of analyst opinions and performance highlights limits a comprehensive analysis.

**7. Overall Analysis:**

UNH has demonstrated strong historical outperformance against the S&P 500. The current price is relatively strong compared to its moving averages, and the PPO suggests positive momentum. Long-term expected returns are considerably high, but come with significant risk due to the volatility in earnings and ROE.  However, some caution is warranted given the significant EPS volatility, mixed signals from recent performance and the lack of contextual data from recent news and analyst opinion. The reported earnings figures show inconsistencies and lack external benchmarks for comparison.  Further investigation into these inconsistencies and obtaining current market outlook and analyst opinions are crucial before making any investment decisions.

**8. Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice.  Investing in the stock market involves risk, and past performance is not indicative of future results.  Always conduct thorough research and consider consulting a financial advisor before making investment decisions.
